Monteiro et al. (2020) (17) performed a review of tissue biomarkers capable of predicting the risk of oral cancer in OL patients and found among 46 studies that the most assessed proteins were again podoplanin and p53. This evidence concerns the gene TP53 and lip and oral cavity carcinoma.